(Q82003861)
Statements
Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study (English)
Yaariv Khaykin
Xiaoyin Wang
Oussama M Wazni
Allan C Skanes
Karin H Humphries
Charles R Kerr
Atul Verma
Carlos A Morillo
17 September 2008